Ashwini Ghogare, MilliporeSigma Head of AI and Automation in Drug Discovery, Joins CDO Magazine Global Editorial Board

(US and Canada) We are pleased to welcome Ashwini Ghogare to CDO Magazine’s Global Editorial Board. Ghogare  is Head of Artificial Intelligence and Automation in Drug Discovery at MilliporeSigma. She  is a leader in transformational AI and automation technologies for drug discovery with extensive experience in software development, new business incubation, and commercial success of software products.

Ghogare heads the AI and Automation for Drug Discovery business unit at MilliporeSigma, where she pioneers AI-powered drug discovery and automation solutions across the Life Sciences and Healthcare sectors. She led the inception and successful launch of a new AI-powered drug design solution, AIDDISON, and the global commercialization of Synthia, MilliporeSigma’s two flagship software products.

Ghogare holds a Ph.D. in organic chemistry in photobiology, focusing on the photochemical drug delivery system for oncology applications, which led to the creation of the startup SingletO2 Therapeutics LLC.

As global thought leaders, CDO Magazine’s Editorial Board of top executives share their expert opinions and innovations in data and analytics. The board ensures that we champion the best companies, leaders, and insights that accelerate our community’s success. Members may serve as editorial writers, reviewers, content developers, and conference speakers.

The CDO Magazine community welcomes Ashwini Ghogare to our growing Global Editorial Board membership.